CJ,
Thank you too for the great info you provided today. You continue to be an anchor point for great info.
Regarding the article's statement that CSM provided services for one of 3 double blind, placebo controlled studies of bavituximab; was that a misprint/mistake? I thought that the 2nd line NSCLC trial was the ONLY double blind, placebo controlled bavituximab trial ever done or currently being done. What am I missing? What are the other two double blind, placebo controlled trials? It would be great to have 2 other double, blind trials going on but I don't think they exist and I think the article was incorrect in this statement.